A few observations on our industry's appetite for data from a recent conversation between colleagues in Europe.

Met with Jane Griffiths, Ph.D., Company Group Chairman, Europe, Middle East and Africa, for Janssen on the state of affairs in oncology.

Talking to CSL CEO Paul Perreault about the need for pharma to better connect with patients, drug pricing and CSL lessons for big pharma.

I recently met with U.S. President of Novartis , for a free-ranging chat about trust in pharma, patient input and driving value.